Research programme: zinc finger protein-based therapeutics - Sangamo/Pfizer

Drug Profile

Research programme: zinc finger protein-based therapeutics - Sangamo/Pfizer

Alternative Names: C9ORF72 ZFP-TF; ZFP TF gene therapy; ZFP-based therapeutics - Sangamo/Pfizer; ZFP-TF gene therapies; Zinc finger protein gene therapy - Pfizer/Sangamo; Zinc finger protein gene therapy - Sangamo/Pfizer; Zinc finger protein transcription factors - Sangamo/Pfizer

Latest Information Update: 09 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sangamo Therapeutics
  • Class Gene therapies; Transcription factors; Zinc finger DNA binding proteins
  • Mechanism of Action DNA binding protein modulators; Genetic transcription modulators; Transcription factor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Amyotrophic lateral sclerosis; Dementia

Most Recent Events

  • 03 Jan 2018 Sangamo Therapeutics enters into a collaboration licensing with Pfizer for the development and commercialisation of zinc finger protein based therapeutics for the treatment of Amyotrophic lateral sclerosis and Dementia
  • 03 Jan 2018 Early research in Amyotrophic lateral sclerosis in USA (Parenteral)
  • 03 Jan 2018 Early research in Dementia in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top